Free Access
Publication ahead of print
Journal
Radioprotection
DOI https://doi.org/10.1051/radiopro/2020050
Published online 20 May 2020
  • Abbas E. 2018. Surgical management of lung cancer: history, evolution, and modern advances. Curr. Oncol. Rep. 20(12): 98. [CrossRef] [PubMed] [Google Scholar]
  • Ball D, et al. 2019. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol. 20(4): 494–503. [CrossRef] [PubMed] [Google Scholar]
  • Bourguignon M, Bérard P, Bertho J, Farah J, Mercat C. 2017. What’s next in radioprotection? Radioprotection 52: 21–28. [CrossRef] [EDP Sciences] [Google Scholar]
  • Chan C, et al. 2014. Intensity-modulated radiotherapy for lung cancer: current status and future developments. J. Thorac. Oncol. 9(11): 1598–1608. [Google Scholar]
  • Chun SG, et al. 2015. Comparison of 3-D conformal and intensity modulated radiation therapy outcomes for locally advanced non-small cell lung cancer in NRG oncology/RTOG 0617. Int. J. Radiat. Oncol. Biol. Phys. 93(3): S1–S2. [Google Scholar]
  • Cosset JM, et al. 2013. Hypofractionnement en radiothérapie : l’éternel retour. Cancer Radiother. 17(5–6): 355–362. [CrossRef] [PubMed] [Google Scholar]
  • Coutard H. 1934. Principles of X-ray therapy of malignant diseases. Lancet 2: 1–12. [Google Scholar]
  • Despeignes V. 1896. Observation concernant un cas de cancer de l’estomac traité par les rayons Rontgen. Lyon Med. 82: 428. [Google Scholar]
  • Dieterich S, et al. 2018. SBRT targets that move with respiration. Phys. Med. 56: 19–24. [CrossRef] [PubMed] [Google Scholar]
  • Durdux C, et al. 2018. Principes et techniques de la radiothérapie thoracique des carcinomes bronchiques non à petites cellules (CBNPC). Rev. Mal. Respir. Actual. 10(3): 303–313. [Google Scholar]
  • Foray N. 2016a. Les origines lyonnaises de la radiothérapie anticancéreuse. Dans : Conférence université de Lyon, 25 mai 2016. https://popsciences.universite-lyon.fr/. [Google Scholar]
  • Foray N. 2016b. Victor Despeignes, the forgotten pioneer of radiation oncology. Int. J. Radiat. Oncol. Biol. Phys. 96(4): 717–721. [CrossRef] [PubMed] [Google Scholar]
  • Franks KN, et al. 2015. Stereotactic ablative body radiotherapy for lung cancer. Clin. Oncol. 27(5): 280–289. [CrossRef] [PubMed] [Google Scholar]
  • Hamaji M. 2019. Surgery and stereotactic body radiotherapy for early-stage non-small cell lung cancer: prospective clinical trials of the past, the present, and the future. Gen. Thorac. Cardiovasc. Surg. Special Edition. [Google Scholar]
  • Hamaji M, et al. 2019. Surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer: review of meta-analyses. J. Thorac. Dis. 11(Suppl. 13): S1646–S1652. [CrossRef] [PubMed] [Google Scholar]
  • Horn L, Johnson DH. 2008. Evarts A. Graham and the first pneumonectomy for lung cancer. J. Clin. Oncol. 26(19): 3268–3275. [CrossRef] [PubMed] [Google Scholar]
  • Khaitan PG, D’Amico TA. 2018. Milestones in thoracic surgery. J. Thorac. Cardiovasc. Surg. 155(6): 2779–2789. [CrossRef] [PubMed] [Google Scholar]
  • Koshy M, et al. 2017. Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy. Lung Cancer 108: 222–227. [CrossRef] [PubMed] [Google Scholar]
  • Koshy M, et al. 2015. Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 91(2): 344–350. [CrossRef] [PubMed] [Google Scholar]
  • Lanni TB, et al. 2011. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer. Am. J. Clin. Oncol. Cancer Clin. Trials 34(5): 494–498. [CrossRef] [Google Scholar]
  • Lefebvre L, et al. 2014. New techniques and potential benefits for radiotherapy of lung cancer. Cancer Radiother. 18(5–6): 473–479. [CrossRef] [PubMed] [Google Scholar]
  • Liao ZX, et al. 2010. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 76(3): 775–781. [CrossRef] [PubMed] [Google Scholar]
  • Menoux I, et al. 2018. Radiation-induced lung toxicity predictors after stereotactic radiation therapy for non-small cell lung carcinoma stage I. Cancer Radiother. 22(8): 826–838. [CrossRef] [PubMed] [Google Scholar]
  • Menten MJ, et al. 2017. MRI-guided lung SBRT: present and future developments. Phys. Med. 44: 139–139. [CrossRef] [PubMed] [Google Scholar]
  • Modlin IM, et al. 2014. A historical appreciation of bronchopulmonary neuroendocrine neoplasia. Thorac. Surg. Clin. 24(3): 235–255. [CrossRef] [PubMed] [Google Scholar]
  • De Neve W, et al. 1999. Modulation d’intensité en radiothérapie par collimateur multi-lame dynamique. Technique et expérience clinique. Cancer Radiother. 3(5): 378–392. [CrossRef] [PubMed] [Google Scholar]
  • Nyman J, et al. 2016. SPACE − A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiother. Oncol. 121(1): 1–8. [PubMed] [Google Scholar]
  • Ochsner A. 1978. The development of pulmonary surgery, with special emphasis on carcinoma and bronchiectasis. Am. J. Surg. 135(6): 732–746. [CrossRef] [PubMed] [Google Scholar]
  • Regaud C, Blanc J. 1906. Action des rayons X sur les diverses générations de la lignée spermatique. Extrême sensibilité des spermatogonies à ces rayons. C. R. Soc. Biol. (202): 892. [Google Scholar]
  • Shimkin MB, et al. 1962. Pneumonectomy and lobectomy in bronchogenic carcinoma. a comparison of end results of the Overholt and Ochsner clinics. J. Thorac. Cardiovasc. Surg. 44: 503–519. [CrossRef] [PubMed] [Google Scholar]
  • Shiu AS, et al. 2003. Near simultaneous computed tomography stereotactic spinal radiotherapy: an emerging paradigm for achieving true stereotaxy. Int. J. Radiat. Oncol. Biol. Phys. 57: 605–613. [CrossRef] [PubMed] [Google Scholar]
  • Solberg JL, et al. 2012. Historical development of stereotactic ablative radiotherapy. Radiat. Oncol. 39(1): 191–197. [Google Scholar]
  • Videtic GM, et al. 2019. Long-term follow-up on NRG oncology RTOG 0915 (NCCTG N0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 103(5): 1077–1084. [CrossRef] [PubMed] [Google Scholar]
  • Widder J, et al. 2011. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 81(4): 291–297. [Google Scholar]
  • Yaprak G, et al. 2019. Is stereotactic body radiotherapy an alternative to surgery in early stage non small cell lung cancer? J. BUON 24(4): 1619–1625. [PubMed] [Google Scholar]
  • Yenice KM, et al. 2003. CT image-guided intensity modulated therapy for paraspinal tumors using stereotactic immobilization. Int. J. Radiat. Oncol. Biol. Phys. 55: 583–593. [CrossRef] [PubMed] [Google Scholar]
  • Yom SS, et al. 2007. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 68(1): 94–102. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.